¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Thallium Myocardial Imaging"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • intravoxel coherent motion imaging
    È­Àû¼Ò³»°áÁý¿îµ¿¿µ»ó
  • intravoxel incoherent motion imaging
    È­Àû¼Ò³»ºñ°áÁý¿îµ¿¿µ»ó
  • imaging
    1. ¿µ»ó, Á¶¿µ 2. ¿µ»óÈ­, ¿µ»ó¹ý 3. »ó»ó
  • imaging gradient
    ¿µ»ó±â¿ï±â
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging sequence
    ¿µ»ó¿¬¼â
  • multislice imaging
    ´ÙÁßÀýÆí¿µ»ó
  • multislice imaging acquisition
    ´ÙÁßÀýÆí¿µ»óȹµæ
  • magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • phase offset multiplanar imaging
    À§»ó¿ÀÇÁ¼Â´Ù¸é¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • real time imaging
    ½Ç½Ã°£¿µ»ó
  • receptor imaging
    1. ¼ö¿ëü¿µ»ó 2. ¼ö¿ëü¿µ»óÈ­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient echo imaging
    ±â¿ï±â¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    ±â¿ï±âÀçÃÊÁ¡¿µ»ó
  • imaging gradient
    ¿µ»ó±â¿ï±â
  • hybrid imaging
    È¥¼º¿µ»ó
  • imaging
    ¿µ»ó, »ó»ó, Á¶¿µ
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging sequence
    ¿µ»ó¿¬¼â
  • intravoxel coherent motion imaging
    È­Àû¼Ò³»°áÁý¿îµ¿¿µ»ó
  • intravoxel incoherent motion imaging
    È­Àû¼Ò³»ºñ°áÁý¿îµ¿¿µ»ó
  • magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • multislice imaging
    ´ÙÁßÀýÆí¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • phase offset multiplannar imaging
    À§»ó¿ÀÇÁ¼Â´Ù¸é¿µ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • phase offset multiplannar (POMP) imaging
    À§»ó ¿ÀÇÁ¼Â ´Ù¸é ¿µ»ó
  • radionuclide imaging
    ¹æ»ç¼º ÇÙÁ¾À̸ÞÀÌ¡.
  • real time imaging
    ½Ç½Ã°£ ¿µ»ó ±â¹ý
  • receptor imaging
    ¼ö¿ëü¿µ»ó(È­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial infarction
    ½É±Ù°æ»öÁõ(¡­ÌÛßáñø).
  • myocardial infarction
    ½É±Ù°æ»öÁõ(¡­ÌÛßáñø)
  • myocardial infarction
    ½É±Ù°æ»ö
  • myocardial infarction,complications of
    ÇÕº´Áõ(ùêܱñø)
  • myocardial infarction,exogeneous estrogens
    ¿ÜÀμº ¿¡½ºÆ®·Î°Õ(èâì×àõ ¡­)
  • myocardial infarction,extension
    ½ÅÀü(ãßî÷)
  • myocardial infarction,outcomes of
    °á¸»(Ì¿ØÇ)
  • myocardial infarction,transmural
    ÀüÃþ°æ»öÁõ(îïöµÌÛßáñø)
  • myocardial infarction,ventricular aneurysm
    ½É½Ç·ù(ãýãø×µ)
  • myocardial infarction,wavy fibers
    ÆÄµ¿Çü ¼¶À¯(÷îÔÑúþ àéë«)
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º.
  • myocardial ischemia
    ½É±ÙÇãÇ÷(¡­úÈúì).
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • myocardial lead
    ½É±ÙÀ¯µµ.
  • myocardial mechanics
    ½É±Ù¿ªÇÐ(¡­æ³ùÊ).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • frequency modulation imaging
    Á֯ļöº¯Á¶¿µ»ó
  • functional brain imaging
    ±â´ÉÀû³ú¿µ»ó
  • functional magnetic resonance imaging [=fMRI]
    ±â´ÉÀûÀÚ±â°ø¸í¿µ»ó
  • gradient acquisition imaging
    °æ»çȹµæ¿µ»ó
  • gradient echo [=GRE] imaging
    °æ»ç¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    °æ»çÀçÃÊÁ¡¿µ»ó
  • half Fourier imaging
    ¹ÝFourier¿µ»ó
  • hybrid imaging
    È¥¼º¿µ»ó
  • imaging
    ¿µ»ó
  • imaging gradient
    ¿µ»ó°æ»ç(ÀÚ°è)
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging of STIR sequence
    STIR¿¬¼â¿µ»ó
  • imaging parameter
    ¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
  • imaging procedure
    ¿µ»óÀýÂ÷
  • imaging procedure
    ¿µ»óÁø´Ü¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MI first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect...
PMI pain management inventory; past medical illness; patient medication instruction; perioperative myoca...
SMI Self-Motivation Inventory; senior medical investigator; severe mental impairment; silent myocardial ...
TAMI thrombolysis and angioplasty in myocardial infarction; transmural anterior myocardial infarction
TIMI trhombolysis in myocardial infarction; transmural inferior myocardial infarction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AMI Anterior myocardial infarction
CK-MB Creatine kinase-myocardial band
MB Myocardial Bridge
MDF Myocardial Depressant Factor
MVO2 Myocardial O2 consumption
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • imaging
    ¿µ»ó, ¿µ»óÈ­
    »ó¿¡¼­, ƯÈ÷ X¼±°ú ÃÊÀ½ÆÄ »ó¿¡¼­ ¼±¸í, ´ëÁ¶ ¹× »ó¼¼¼ºÀ» »ý¼ºÇÏ´Â °Í. ¹æ»ç¼± »çÁø, ÃÊÀ½ÆÄ, ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ ±×¸®°í Àڱ⠰ø¸í»ó°ú °°ÀÌ Áø´Ü ¸ñÀûÀ¸·Î ±¸Á¶¹°À» º¸¿©Áְųª À̸¦ ½Ã°¢ÀûÀ¸·Î ÀçÇü¼ºÇÑ °Í.
  • imaging modality
    ¿µ»ó ¹æ½Ä
  • imaging parameter
    ¿µ»ó ÁöÇ¥, ¿µ»ó º¯¼ö
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • intravoxel coherent motion imaging
    º¹¼¿³» °áÁý ¿îµ¿ ¿µ»ó
  • magnetization transfer imaging
    ÀÚÈ­ Àü´Þ ¿µ»ó
  • multiecho imaging
    ´ÙÁß ¿¡ÄÚ ¿µ»ó
  • multiphase cardiac imaging
    ´ÙÁß À§»ó ½ÉÀå ¿µ»ó
  • partial echo imaging
    ºÎºÐ ¿¡ÄÚ ¿µ»ó
  • partial volume imaging
    ºÎºÐ ¿ëÀû ¿µ»ó
  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • radionuclide imaging
    ¹æ»ç¼º ÇÙÁ¾ »ó
  • shock wave imaging
    Ãæ°ÝÆÄ »ó
  • spin echo intravoxel incoherent motion imaging
    ½ºÇÉ ¿¡ÄÚÈ­ Àû¼Ò³» ºñ°áÁý ¿îµ¿ ¿µ»ó¼ú
  • stop action imaging
    Á¤Áö »óÅ ¿µ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myocardial stunning Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue.
(12 Dec 1998)
posterior myocardial infarction Infarction involving the posterior wall of the heart; also formerly used erroneously of infarction's involving the inferior or diaphragmatic surface of the heart.
(05 Mar 2000)
silent myocardial infarction Infarction that produces none of the characteristic symptoms and signs of myocardial infarction.
(05 Mar 2000)
subendocardial myocardial infarction Infarction that involves only the layer of muscle subjacent to the endocardium.
(05 Mar 2000)
nontransmural myocardial infarction Necrosis of heart muscle that fails to extend from the endocardium to the epicardium, often erroneously considered relatively benign.
(05 Mar 2000)
diaphragmatic myocardial infarction Infarction in which the inferior or diaphragmatic wall of the heart is involved, producing indicative changes in leads II, III, and aVF in the electrocardiogram.
Synonym: diaphragmatic myocardial infarction.
(05 Mar 2000)
inferior myocardial infarction Infarction in which the inferior or diaphragmatic wall of the heart is involved, producing indicative changes in leads II, III, and aVF in the electrocardiogram.
Synonym: diaphragmatic myocardial infarction.
(05 Mar 2000)
inferolateral myocardial infarction Infarction involving the inferior and lateral surfaces of the heart and producing indicative changes in the electrocardiogram in leads II, III, aVF, V5, and V6.
(05 Mar 2000)
ischemic preconditioning, myocardial Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ischemia or reperfusion. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.
(12 Dec 1998)
through-and-through myocardial infarction Infarction that involves the whole thickness of the heart muscle from endocardium to epicardium.
Synonym: through-and-through myocardial infarction.
(05 Mar 2000)
transmural myocardial infarction Infarction that involves the whole thickness of the heart muscle from endocardium to epicardium.
Synonym: through-and-through myocardial infarction.
(05 Mar 2000)
lateral myocardial infarction Infarction involving only the lateral wall of the heart, producing indicative electrocardiographic changes confined to leads I, aVL, V5, and V6.
(05 Mar 2000)
adrenal imaging <radiology> Cortex, I-131 iodo-cholesterol, not widely used due to high rad dose and 4-15 day delayed imaging, medulla, search for pheo, MIBG (I-131 meta-iodobenzylguanidine)
(12 Dec 1998)
adrenal medullary imaging <investigation, radiology> A nuclear scan that images the adrenal glands after a radioactive tracer is injected into the bloodstream. This test is useful in detecting a pheochromocytoma, particularly if it not within the adrenal gland.
(27 Sep 1997)
backscattered electron imaging <microscopy> The production of backscattered electrons from a sample varies directly with the specimen's average atomic number, higher atomic number elements produce more backscattered electrons than lower atomic number ones. Detection of Backscattered Electrons is achieved by using a donut shaped solid state saemiconductor device mounted on the bottom of the objective lens. When Backscattered Electrons strike the detector electron-hole pairs are created which are then counted. This quantity is translated into a pixel intensity and displayed on the CRT, forming the image. By splitting the detector into halves (or quadrants) differences in the signal level on the individual detector segments provide surface topography information.
(05 Aug 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á